Ara
Toplam kayıt 1, listelenen: 1-1
Ibrutinib as a promising treatment for pulmonary complications due to refractory chronic graft versus host disease
(Elsevier Science Inc, 2020)
Introduction: Despite major improvements in allogeneic hematopoetic stem cell transplantation form matched related/ unrelated donor over last decades, chronic graft-versus-host disease (cGVHD) is still the leading cause ...